跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Spire - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Spire
Approved
STANDARD
Spire
Mepro Pharmaceuticals Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f0ff603dd2bd7fb5
Company
Mepro Pharmaceuticals Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
f0ff603dd2bd7fb5
Drug Approval Philippines Name
Spire
Product Name
Spire
Registration Number
DRP-4711
Brand Name
Spire
Generic Name
Spironolactone
Dosage Form
Film Coated Tablet
Dosage Strength
50 mg
Manufacturer
Mepro Pharmaceuticals Pvt. Ltd.
Importer
MedEthix, Inc.
Distributor
MedEthix, Inc.
Issuance Date
28 February 2022
Expiry Date
23 October 2027
Pharmacologic Category
Antialdosterone/Renin Angiotensin Aldosterone (RAA) Modulator
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f0ff603dd2bd7fb5
Type
Standard
Back to Philippines FDA Approvals